Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Prostatic Neoplasms 18Burkitt Lymphoma 14Lymphoma, Large B-Cell, Diffuse 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6Lymphoma, B-Cell 4Lymphoma, T-Cell 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma, Large-Cell, Anaplastic 2Immunoblastic Lymphadenopathy 2Hodgkin Disease 2Enteropathy-Associated T-Cell Lymphoma 2Blast Crisis 2Vasculitis, Central Nervous System 1Urogenital Neoplasms 1Stiff-Person Syndrome 1Stage II Prostate Adenocarcinoma 1Rasmussen subacute encephalitis 1Polyradiculoneuropathy, Chronic Inflammatory Demyelinating 1Plasmablastic Lymphoma 1Oropharyngeal Neoplasms 1Opsoclonus-Myoclonus Syndrome 1Neuromyelitis Optica 1Myelodysplastic Syndromes 1Myasthenia Gravis 1Multi-centric Castleman's Disease 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Lymphoma 1Lung Neoplasms 1

Interventions

deltacortene 1Vincristine 1Rituximab 1Prednisone 1Methotrexate 1Hyaluronoglucosaminidase 1Etoposide 1Doxorubicin 1Cyclophosphamide 1CT-P10 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Multi-centric Castleman's Disease × deltacortene × Clear all
NCT03864419 2024-01-03

Rituximab Hyaluronidase in Combination With Chemotherapy in Treating Aggressive B-cell Lymphoma in Uganda

Fred Hutchinson Cancer Center

Phase 1 Terminated
18 enrolled
Lymphoid

Multi-centric Castleman's Disease, Burkitt Lymphoma, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡